← Back to the feed

ZuriMED Technologies AG

History from 2 Nov 2017

UID

CHE-443.849.572

Legal form

AG

Canton

ZH

Founded

not in the record

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 14 Jun 2021 · legal date 7 Jun 2021

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   112’356 → 172’355

   Shares

   112’356 → 172’355

   New shares, % of post-step shares

   34.8% (59’999 new)

   Aktienkapital neu: CHF 172'355.00 [bisher: CHF 112'356.00]. Liberierung Aktienkapital neu: CHF 172'355.00 [bisher: CHF 112'356.00]. Aktien neu: 172'355 Namenaktien zu CHF 1.00 [bisher: 112'356 Namenaktien zu CHF 1.00].

   SHAB HR02-1005215762 ↗

2. SHAB published 4 Jul 2022 · legal date 28 Jun 2022

   Capital increase

   Not assessed

   Paid in cash and by other means

   Nominal capital

   172’355 → 232’488

   Shares

   172’355 → 232’488

   New shares, % of post-step shares

   25.9% (60’133 new)

   Aktienkapital neu: CHF 232'488.00 [bisher: CHF 172'355.00]. Liberierung Aktienkapital neu: CHF 232'488.00 [bisher: CHF 172'355.00]. Aktien neu: 232'488 Namenaktien zu CHF 1.00 [bisher: 172'355 Namenaktien zu CHF 1.00].

   SHAB HR02-1005510939 ↗

3. SHAB published 3 Jul 2023 · legal date 27 Jun 2023

   Capital increase

   Not assessed

   Paid in cash and by other means

   Nominal capital

   232’488 → 298’613

   Shares

   232’488 → 298’613

   New shares, % of post-step shares

   22.1% (66’125 new)

   Aktienkapital neu: CHF 298'613.00 [bisher: CHF 232'488.00]. Liberierung Aktienkapital neu: CHF 298'613.00 [bisher: CHF 232'488.00]. Aktien neu: 298'613 Namenaktien zu CHF 1.00 [bisher: 232'488 Namenaktien zu CHF 1.00].

   SHAB HR02-1005784086 ↗

4. SHAB published 9 Jan 2025 · legal date 12 Dec 2024

   Capital increase

   Not assessed

   Issued from conditional capital

   Nominal capital

   298’613 → 318’090

   Shares

   298’613 → 318’090

   New shares, % of post-step shares

   6.1% (19’477 new)

   Aktienkapital neu: CHF 318'090.00 [bisher: CHF 298'613.00]. Liberierung Aktienkapital neu: CHF 318'090.00 [bisher: CHF 298'613.00]. Aktien neu: 318'090 Namenaktien zu CHF 1.00 [bisher: 298'613 Namenaktien zu CHF 1.00]. Partizipationskapital neu: CHF 3'817.00. Liberierung Partizipationskapital neu: CHF 3'817.00. Partizipationsscheine neu: 3'817 Namen-Partizipationsscheine zu CHF 1.00. Erhöhung Partizipationskapital aus bedingtem Partizipationskapital.

   SHAB HR02-1006223203 ↗

5. SHAB published 9 Oct 2025 · legal date 3 Oct 2025

   Capital increase

   ○○○Capital increased

   Issued from conditional capital

   Nominal capital

   318’090 → 465’378

   Shares

   318’090 → 465’378

   New shares, % of post-step shares

   31.6% (147’288 new)

   Aktienkapital neu: CHF 465'378.00 [bisher: CHF 318'090.00]. Liberierung Aktienkapital neu: CHF 465'378.00 [bisher: CHF 318'090.00]. Aktien neu: 465'378 Namenaktien zu CHF 1.00 [bisher: 318'090 Namenaktien zu CHF 1.00]. Partizipationskapital neu: CHF 10'276.00 [bisher: CHF 3'817.00]. Liberierung Partizipationskapital neu: CHF 10'276.00 [bisher: CHF 3'817.00]. Partizipationsscheine neu: 10'276 Namen-Partizipationsscheine zu CHF 1.00 [bisher: 3'817 Namen-Partizipationsscheine zu CHF 1.00]. Erhöhung Partizipationskapital aus bedingtem Partizipationskapital.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5
   • Shares issued out of conditional capital, as when options are exercised.−1.0

   Classifier score 0.15 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006453708 ↗

6. SHAB published 18 Dec 2025 · legal date 12 Dec 2025

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   465’378 → 491’206

   Shares

   465’378 → 491’206

   New shares, % of post-step shares

   5.3% (25’828 new)

   Aktienkapital neu: CHF 491'206.00 [bisher: CHF 465'378.00]. Liberierung Aktienkapital neu: CHF 491'206.00 [bisher: CHF 465'378.00]. Aktien neu: 491'206 Namenaktien zu CHF 1.00 [bisher: 465'378 Namenaktien zu CHF 1.00].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006516978 ↗

Published by 21 Dec 2025

Latest available record · 8 Oct 2026